Study to Evaluate the Safety, Tolerability, PK, and PD of BMS-986090 in Healthy Subjects

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Healthy Adult Volunteers

In brief

The purpose of this study is to evaluate the safety and tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of BMS-986090 in healthy subjects.

Key facts

Study ID

NCT02079480

Run by

Bristol-Myers Squibb

People needed

130

Starts

2014-05-01

Expected to finish

2016-04-01

Last updated by the study team

2016-05-12

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy male and female (of not childbearing potential), ages 18-45 years, inclusive
• BMI 18 to 32 kg/m2, inclusive

You may not qualify if…

• Any significant acute or chronic medical illness

Where it is running

• California Clinical Trials Medical Group — Glendale, California, United States
• Parexel Baltimore Early Phase Clinical Unit — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.